In the Global Patient Blood Management Market Research Report published by Emergen Research, key business details are analyzed along with a geographical overview of the Patient Blood Management industry, which provides extensive analysis of this sector. This study provides a comprehensive look at the Patient Blood Management market from both a qualitative and quantitative perspective as well as crucial statistical information about the market. As of 2024, the research study provides historical data and offers forecasts up to 2032. Furthermore, the report describes emerging and established players of the market, providing an overview of their business, their product portfolio, their strategic alliances, and their plans for expansion.
The global Patient Blood Management (PBM) market size is expected to reach USD 27.15 Billion in 2032 and register a steady revenue CAGR of 7.4% during the forecast period, according to latest analysis by Emergen Research. Increasing frequency of target diseases, such as anemia and iron deficiency, is a major factor driving market revenue growth. For instance, the important public health issue of anemia disproportionately affects young children and expectant mothers. According to World Health Organization (WHO) statistics, anemia affects 40% of pregnant women and 42% of children under the age of five globally. PBM mainly detects patients who need blood transfusions and offers a management strategy aiming at lowering or eliminating risk of anemia and requirement for allogeneic transfusion, hence lowering inherent hazards, inventory pressures, and rising costs related to transfusion, driving market revenue growth.
In the Global Patient Blood Management Market Research Report published by Emergen Research, key business details are analyzed along with a geographical overview of the Patient Blood Management industry, which provides extensive analysis of this sector. This study provides a comprehensive look at the Patient Blood Management market from both a qualitative and quantitative perspective as well as crucial statistical information about the market. As of 2024, the research study provides historical data and offers forecasts up to 2032. Furthermore, the report describes emerging and established players of the market, providing an overview of their business, their product portfolio, their strategic alliances, and their plans for expansion.
The global Patient Blood Management (PBM) market size is expected to reach USD 27.15 Billion in 2032 and register a steady revenue CAGR of 7.4% during the forecast period, according to latest analysis by Emergen Research. Increasing frequency of target diseases, such as anemia and iron deficiency, is a major factor driving market revenue growth. For instance, the important public health issue of anemia disproportionately affects young children and expectant mothers. According to World Health Organization (WHO) statistics, anemia affects 40% of pregnant women and 42% of children under the age of five globally. PBM mainly detects patients who need blood transfusions and offers a management strategy aiming at lowering or eliminating risk of anemia and requirement for allogeneic transfusion, hence lowering inherent hazards, inventory pressures, and rising costs related to transfusion, driving market revenue growth.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/1757